MTPH

MIDATECH PHARMA PLC ORD 0.1P

TitleTime
Form 8.3 - Midatech Pharma plcFri 22/05/20 | 16:02
Rule 2.9 AnnouncementFri 22/05/20 | 09:56
Rule 2.9 AnnouncementThu 21/05/20 | 07:01
Closing of US$3.0m Registered Direct OfferingThu 21/05/20 | 07:00
Form 8.5 (EPT/RI)Wed 20/05/20 | 11:36
Correction: UK Placing to Raise £1.8 millionTue 19/05/20 | 11:10
US$3.0 Million Registered Direct OfferingMon 18/05/20 | 14:08
Headline Results for the Year Ended 31 Dec 2019Mon 18/05/20 | 07:00
Form 8.5 (EPT/RI)Wed 13/05/20 | 11:28
Amendment to Relationship AgreementTue 12/05/20 | 17:17
Form 8.3 - Midatech Pharma plcTue 05/05/20 | 10:54
Second Price Monitoring ExtnMon 04/05/20 | 16:41
Price Monitoring ExtensionMon 04/05/20 | 16:35
Form 8.5 (EPT/RI)Mon 04/05/20 | 11:28
Form 8 (OPD) (Midatech Pharma plc)Mon 04/05/20 | 07:00
Statement regarding Price MovementFri 01/05/20 | 11:08
Second Price Monitoring ExtnThu 30/04/20 | 16:42
Price Monitoring ExtensionThu 30/04/20 | 16:36
Rule 2.9 Announcement - Typo CorrectionWed 22/04/20 | 15:51
Form 8.3 - Midatech Pharma Plc - ReplacementWed 22/04/20 | 12:00
Form 8.3 - Link Fund Solutions Ltd: Midatech Pharma PlcWed 22/04/20 | 11:42
Strategic Review Update, Formal Sale ProcessMon 20/04/20 | 07:00
Strategic Review, Update and Directorate ChangesTue 31/03/20 | 07:00
Result of General MeetingMon 02/03/20 | 15:48
Midatech Expands MTX110 DIPG ProgrammeMon 02/03/20 | 07:00
Second Price Monitoring ExtnThu 13/02/20 | 14:05
Price Monitoring ExtensionThu 13/02/20 | 14:00
Notice of General MeetingWed 12/02/20 | 14:13
Second Price Monitoring ExtnWed 08/01/20 | 16:41
Price Monitoring ExtensionWed 08/01/20 | 16:35
Positive Results from MTD201-102 StudyWed 08/01/20 | 07:00
Receipt of NASDAQ NoticeMon 16/12/19 | 07:00
Euro 2.6m Grant for clinical development of MTX110Thu 05/12/19 | 14:00
Holding(s) in CompanyThu 05/12/19 | 07:00
Holding(s) in CompanyMon 04/11/19 | 17:41
Holding(s) in CompanyThu 31/10/19 | 18:12
Holding(s) in CompanyThu 31/10/19 | 09:26
Total Voting RightsMon 28/10/19 | 07:01
Closing of US$3.0m Registered Direct OfferingMon 28/10/19 | 07:00
MTX110 Receives Orphan Designation for DIPGThu 24/10/19 | 07:00
US$3.0m Registered Direct OfferingWed 23/10/19 | 07:08
Holding(s) in CompanyThu 17/10/19 | 14:23
Holding(s) in CompanyTue 15/10/19 | 14:59
Commencement of MTD201 Phase 1 StudyTue 08/10/19 | 07:00
PDMR DealingMon 07/10/19 | 07:00
Issue of Equity for Employee Share Incentive PlanMon 07/10/19 | 07:00
PDMR DealingFri 04/10/19 | 07:00
PDMR DealingThu 03/10/19 | 07:00
Award of Options to a DirectorWed 02/10/19 | 10:19
PDMR DealingWed 02/10/19 | 07:00
Interim ResultsMon 30/09/19 | 07:13
Filing of U.S. Shelf RegistrationTue 24/09/19 | 07:00
MTD201 Phase 1 Study ApprovalFri 20/09/19 | 07:00
Receipt of Spanish Government LoanWed 11/09/19 | 10:05
Directorate ChangeMon 09/09/19 | 07:00
Appointment of Non-Executive DirectorWed 31/07/19 | 07:00
Second Price Monitoring ExtnFri 19/07/19 | 16:40
Price Monitoring ExtensionFri 19/07/19 | 16:35
MTX102 Safety ResultsFri 19/07/19 | 07:00
MTX110 UpdateWed 03/07/19 | 09:30
Result of AGMWed 19/06/19 | 12:00
MTD201 Development PlanThu 13/06/19 | 07:00
Posting of Annual Report & Notice of AGMFri 24/05/19 | 17:25
Receipt of NASDAQ NotificationFri 26/04/19 | 16:30
Second Price Monitoring ExtnThu 25/04/19 | 16:40
Price Monitoring ExtensionThu 25/04/19 | 16:35
Second Price Monitoring ExtnWed 24/04/19 | 16:40
Price Monitoring ExtensionWed 24/04/19 | 16:35
Second Price Monitoring ExtnWed 24/04/19 | 14:05
Price Monitoring ExtensionWed 24/04/19 | 14:00
Final ResultsWed 24/04/19 | 07:00
Second Price Monitoring ExtnTue 09/04/19 | 16:41
Price Monitoring ExtensionTue 09/04/19 | 16:35
Second Price Monitoring ExtnFri 05/04/19 | 11:05
Price Monitoring ExtensionFri 05/04/19 | 11:00
Second Price Monitoring ExtnFri 29/03/19 | 14:06
Price Monitoring ExtensionFri 29/03/19 | 14:00
Spanish Government Loan ApprovalFri 29/03/19 | 07:00
ADR Ratio ChangeWed 20/03/19 | 07:00
Second Price Monitoring ExtnThu 28/02/19 | 16:41
Price Monitoring ExtensionThu 28/02/19 | 16:36
Second Price Monitoring ExtnThu 28/02/19 | 11:05
Price Monitoring ExtensionThu 28/02/19 | 11:00
Second Price Monitoring ExtnWed 27/02/19 | 16:40
Price Monitoring ExtensionWed 27/02/19 | 16:35
Holding(s) in CompanyWed 27/02/19 | 10:52
Finalisation of Licence AgreementTue 26/02/19 | 11:26
Result of the General Meeting and Board changesMon 25/02/19 | 12:23
Posting of Circular and Notice of General MeetingFri 08/02/19 | 16:39
Result of PlacingMon 04/02/19 | 18:32
Proposed Placing and Open OfferMon 04/02/19 | 15:16
Strategic Investment & Licence AgreementTue 29/01/19 | 09:23
FDA feedback on clinical plan for MTD201Fri 25/01/19 | 07:00
Holding(s) in CompanyTue 15/01/19 | 13:56
Holding(s) in CompanyTue 15/01/19 | 09:36
Holding(s) in CompanyFri 11/01/19 | 10:58
Midatech announces EUR 1.5 million loan facilityThu 10/01/19 | 11:15
Corporate update and potential fundraiseThu 20/12/18 | 07:00
Midatech Announces Microsphere PartnershipThu 20/12/18 | 07:00
Holding(s) in CompanyWed 28/11/18 | 13:17
Holding(s) in CompanyTue 20/11/18 | 12:59
Holding(s) in CompanyMon 05/11/18 | 09:55
NASDAQ Minimum Bid Price ExtensionThu 01/11/18 | 17:48
Completion of Midatech Pharma US SaleThu 01/11/18 | 07:00
Result of General MeetingMon 15/10/18 | 12:17
Posting of Circular and Notice of General MeetingFri 28/09/18 | 10:04
Interim ResultsThu 27/09/18 | 07:01
Proposed Sale of Midatech Pharma US IncThu 27/09/18 | 07:00
Notice of Interim ResultsThu 06/09/18 | 07:00
Interim results from MTD201 exploratory studyFri 31/08/18 | 07:00
Issue of Equity for Midatech Share Incentive PlanWed 01/08/18 | 07:00
Trading UpdateWed 25/07/18 | 07:00
US Co-Promotion AgreementMon 23/07/18 | 07:00
Result of AGMWed 27/06/18 | 10:56
Midatech US enrols patient in Gelclair trialFri 08/06/18 | 07:00
Board changeFri 01/06/18 | 07:00
2017 Annual Report and AGM NotificationFri 01/06/18 | 07:00
Midatech commences US clinical study with MTX110Fri 25/05/18 | 07:00
Midatech commences dosing in equivalence studyMon 21/05/18 | 07:00
Stmnt re Share Price MovementThu 03/05/18 | 07:00
Second Price Monitoring ExtnWed 02/05/18 | 16:40
Price Monitoring ExtensionWed 02/05/18 | 16:35
Financial results for year ended 31 December 2017Mon 23/04/18 | 07:00
Notice of ResultsMon 09/04/18 | 08:25
Changes in Senior Management TeamThu 15/03/18 | 07:00
Midatech gets Orphan Drug Designation for MTD119Wed 28/02/18 | 07:00
Trading UpdateWed 14/02/18 | 07:00
IND approval for DIPG treatment MTX110Tue 16/01/18 | 07:00
Q-Octreotide first in-human EU study approvedTue 09/01/18 | 07:00
Holding(s) in CompanyWed 03/01/18 | 13:36
Midatech Loan Agreement with MidCap FinancialTue 02/01/18 | 07:00
Midatech initiates Gelclair Phase IV trialWed 20/12/17 | 07:00
Midatech receives manufacturing certificationWed 22/11/17 | 07:00
Issue of Equity for Midatech Share Incentive PlanTue 07/11/17 | 09:35
Holding(s) in CompanyThu 19/10/17 | 10:52
Holdings in CompanyThu 19/10/17 | 09:44
Result of General MeetingMon 16/10/17 | 12:44
Result of Placing to raise £6m & PDMR ShareholdingThu 28/09/17 | 14:35
Interim Results 2017Thu 28/09/17 | 07:01
Proposed Placing and Open OfferThu 28/09/17 | 07:00
Holding(s) in CompanyThu 21/09/17 | 09:00
Notice of interim resultsThu 07/09/17 | 07:00
Midatech submits MTD201 CTA filingMon 04/09/17 | 07:00
Holding(s) in CompanyFri 25/08/17 | 13:59
Trading Update and Notice of ResultsTue 18/07/17 | 07:00